Selective Lateral Pelvic Lymph Dissection for Rectal Cancer George J. Chang Colorectal Cancer 27 September 2017 Pages: 3797 - 3798
“Total Mesenteric Peritonectomy for Peritoneal Metastases” (with Video) by Jean-Baptiste Cazauran et al. Paul H. Sugarbaker Gastrointestinal Oncology 10 October 2017 Pages: 3799 - 3800
Discussion of “Microsurgical Reconstruction Following Oncologic Resection in Pediatric Patients: A 15-Year Experience” by M. Starnes-Roubaud et al. Rebecca M. GarzaDavid W. Chang Reconstructive Oncology 01 September 2017 Pages: 3801 - 3802
Isolated Limb Perfusion and Infusion for Extremity Soft Tissue Sarcoma: A Contemporary Systematic Review and Meta-Analysis Madalyn G. NeuwirthYun SongGiorgos C. Karakousis Bone and Soft Tissue Sarcomas 11 October 2017 Pages: 3803 - 3810
Institutional Experience with Ostomies Created During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion Sam PakraftarLekshmi RamalingamHaroon A. Choudry Colorectal Cancer 10 October 2017 Pages: 3811 - 3817
Recurrence of Optimally Treated Malignant Peritoneal Mesothelioma with Cytoreduction and Heated Intraperitoneal Chemotherapy Danielle R. HellerCody ChiuzanMichael D. Kluger Gastrointestinal Oncology 12 October 2017 Pages: 3818 - 3824
Frailty Correlates with Postoperative Mortality and Major Morbidity After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Ioannis T. KonstantinidisKonstantinos ChouliarasKonstantinos I. Votanopoulos Gastrointestinal Oncology 10 October 2017 Pages: 3825 - 3830
Conflicting Data on the Incidence of Leukopenia and Neutropenia After Heated Intraperitoneal Chemotherapy with Mitomycin C Yael FefermanShanel BhagwandinUmut Sarpel Gastrointestinal Oncology 12 October 2017 Pages: 3831 - 3836
Antimicrobial Properties of Perfusate Fluid After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CS-HIPEC) with Mitomycin C Krystle N. LangeDanielle McKayJan Franko Gastrointestinal Oncology 10 October 2017 Pages: 3837 - 3841
Isolated Limb Infusion: A Single-Center Experience with Over 200 Infusions Cristina O’DonoghueMatthew C. PerezJonathan S. Zager Melanomas 10 October 2017 Pages: 3842 - 3849
Inspection of Perirectal Lymph Nodes by One-Step Nucleic Acid Amplification Predicts Lateral Lymph Node Metastasis in Advanced Rectal Cancer Yuichiro MiyakeTsunekazu MizushimaHirofumi Yamamoto Colorectal Cancer 18 September 2017 Pages: 3850 - 3856
Individualized Treatment Sequencing Selection Contributes to Optimized Survival in Patients with Rectal Cancer and Synchronous Liver Metastases Claudius ConradJean-Nicolas VautheyY. Nancy You Colorectal Cancer 19 September 2017 Pages: 3857 - 3864
Size and Location are the Most Important Risk Factors for Malignant Behavior in Resected Solitary Fibrous Tumors Sepideh GholamiMichael R. CassidyMurray Brennan Bone and Soft Tissue Sarcomas 16 October 2017 Pages: 3865 - 3871
Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303 R. De SanctisL. GiordanoA. Gronchi Bone and Soft Tissue Sarcomas 17 October 2017 Pages: 3872 - 3879
Performance Analysis of the American Joint Committee on Cancer 8th Edition Staging System for Retroperitoneal Sarcoma and Development of a New Staging Algorithm for Sarcoma-Specific Survival Justin M. M. Cates Bone and Soft Tissue Sarcomas 20 October 2017 Pages: 3880 - 3887
Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy Shirin MuhsenAndrea V. BarrioKimberly J. Van Zee Breast Oncology 21 August 2017 Pages: 3888 - 3895
Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer Lori F. GentileGeorge PlitasAndrea V. Barrio Breast Oncology 15 September 2017 Pages: 3896 - 3902
Cost-effectiveness Analysis of Contralateral Prophylactic Mastectomy Compared to Unilateral Mastectomy with Routine Surveillance for Unilateral, Sporadic Breast Cancer Robert C. KeskeyA. Scott LaJoieNicolas Ajkay Breast Oncology 16 October 2017 Pages: 3903 - 3910
Discrepancy Between Clinical and Pathologic Nodal Status of Esophageal Cancer and Impact on Prognosis and Therapeutic Strategy Sheraz R. MarkarCaroline Gronnieron Behalf of the FREGAT Working Group—FRENCH—AFC Gastrointestinal Oncology Open access 25 September 2017 Pages: 3911 - 3920
Outcome with Primary En-bloc Esophagectomy for Submucosal Esophageal Adenocarcinoma Katrin SchwameisKyle M. GreenSteven R. DeMeester Gastrointestinal Oncology 03 October 2017 Pages: 3921 - 3925
Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis Brett L. EckerCharles C. ViningJashodeep Datta Gastrointestinal Oncology 26 September 2017 Pages: 3926 - 3933
The Surgical Apgar Score Predicts Not Only Short-Term Complications But Also Long-Term Prognosis After Esophagectomy Akio NakagawaTetsu NakamuraYoshihiro Kakeji Gastrointestinal Oncology 06 October 2017 Pages: 3934 - 3946
Cross-Sectional Location of Gastric Cancer Affects the Long-Term Survival of Patients as Tumor Invasion Deepens Yoon Ju JungHo Seok SeoHan Hong Lee Gastrointestinal Oncology 04 October 2017 Pages: 3947 - 3953
Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma Suguru YamashitaMichael J. OvermanClaudius Conrad Gastrointestinal Oncology 04 October 2017 Pages: 3954 - 3963
Comparison of Young Patients with Gastric Cancer in the United States and China Vivian E. StrongAshley RussoChang-Ming Huang Gastrointestinal Oncology 19 October 2017 Pages: 3964 - 3971
Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome Michael J. CavnarLin WangPhilip B. Paty Gastrointestinal Oncology 20 October 2017 Pages: 3972 - 3980
The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer Glauco BaiocchiHenrique MantoanAlexandre Andre Balieiro Anastacio da Costa Gynecologic Oncology 20 October 2017 Pages: 3981 - 3987
Total Mesenteric Peritonectomy for Peritoneal Metastases (with video) Jean-Baptiste CazauranAntoinette LasseurOlivier Glehen Gastrointestinal Oncology 06 October 2017 Pages: 3988 - 3989
Ex Situ Hepatectomy and Liver Autotransplantation for Cholangiocarcinoma Emilio VicenteYolanda QuijanoRiccardo Caruso Hepatobiliary Tumors 11 October 2017 Pages: 3990 - 3990
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases Mark B. FariesNicola MozzilloMMAIT-IV Clinical Trial Group Melanomas 10 October 2017 Pages: 3991 - 4000
Chemoradiation Therapy for Unresected Extrahepatic Cholangiocarcinoma: A Propensity Score-Matched Analysis Anna TorgesonShane LloydRanda Tao Radiation Oncology 17 October 2017 Pages: 4001 - 4008
Microsurgical Reconstruction Following Oncologic Resection in Pediatric Patients: A 15-Year Experience Margaret J. Starnes-RoubaudMatthew M. HanasonoEdward I. Chang Reconstructive Oncology 07 September 2017 Pages: 4009 - 4016
High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma Pinjie BaoTakehiko YokoboriHiroyuki Kuwano Thoracic Oncology 20 September 2017 Pages: 4017 - 4024
High Expression of the Mitophagy-Related Protein Pink1 is Associated with a Poor Response to Chemotherapy and a Poor Prognosis for Patients Treated with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Kotaro YamashitaHiroshi MiyataYuichiro Doki Translational Research and Biomarkers 11 October 2017 Pages: 4025 - 4032
Expression of 3β-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status Yuan-Ching ChangChi-Kuan ChenChien-Liang Liu Translational Research and Biomarkers 25 July 2017 Pages: 4033 - 4041
Expression and Clinical Significance of Herpes Virus Entry Mediator (HVEM) in Breast Cancer Julia Y. S. TsangKit-Wing ChanGary M. Tse Translational Research and Biomarkers 13 June 2017 Pages: 4042 - 4050
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival Callisia N. ClarkeMichael S. LeeScott Kopetz Translational Research and Biomarkers 21 September 2017 Pages: 4051 - 4058
Loss of Stromal Antigen 2 (STAG2) Expression in Upper Urinary Tract Carcinoma: Differential Prognostic Effect According to the Ki-67 Proliferating Index Jimpei MiyakawaTeppei MorikawaMasashi Fukayama Urologic Oncology 02 October 2017 Pages: 4059 - 4066
Prognostic Significance of Pre- to Postoperative Dynamics of the Prognostic Nutritional Index for Patients with Renal Cell Carcinoma Who Underwent Radical Nephrectomy Minyong KangChun Tae ChangHyun Moo Lee Urologic Oncology 03 October 2017 Pages: 4067 - 4075
